These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28847534)

  • 1. Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.
    Shimojima Y; Kishida D; Sekijima Y
    Cytokine; 2017 Nov; 99():305-309. PubMed ID: 28847534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.
    Ikeda J; Shimojima Y; Usami Y; Ueno KI; Kishida D; Sekijima Y
    Clin Rheumatol; 2020 Jun; 39(6):1803-1811. PubMed ID: 32036585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
    Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
    Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
    Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
    Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
    Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
    Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
    George-Chandy A; Trysberg E; Eriksson K
    Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Colliver JA; Ness JM; Ransohoff RM
    J Neuroinflammation; 2013 Jan; 10():10. PubMed ID: 23324534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
    Deng B; Liu XN; Li X; Zhang X; Quan C; Chen XJ
    J Neuroimmunol; 2017 Apr; 305():84-91. PubMed ID: 28284352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
    Shimojima Y; Sekijima Y
    Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
    Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
    J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
    Lenert A; Lenert P
    Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell-activating factor belonging to the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) levels in cerebrospinal fluid of patients with meningoencephalitis.
    Kimura A; Yoshikura N; Koumura A; Hayashi Y; Inuzuka T
    J Neurol Sci; 2015 May; 352(1-2):79-83. PubMed ID: 25847017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of hypertrophic spinal pachymeningitis associated with MPO-ANCA].
    Yakushiji Y; Kurohara K; Toda S; Abe M; Kuroda Y
    Rinsho Shinkeigaku; 2002 Sep; 42(9):873-7. PubMed ID: 12710088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis.
    Shimojima Y; Kishida D; Ichikawa T; Takamatsu R; Nomura S; Sekijima Y
    Clin Exp Immunol; 2023 Jul; 213(1):125-137. PubMed ID: 36794867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
    J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of BAFF and APRIL as direct indicators of disease activity in anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.
    Shimojima Y; Kishida D; Nomura S; Sekijima Y
    Clin Rheumatol; 2020 Oct; 39(10):3145-3148. PubMed ID: 32621082
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of BAFF and APRIL in the cerebrospinal fluid based on the therapeutic response in primary central nervous system B-cell lymphoma.
    Ikeda J; Shimojima Y; Yoshinaga T; Kodaira M; Nishina S; Ito K; Sekijima Y
    J Clin Neurosci; 2020 Nov; 81():72-75. PubMed ID: 33222973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis].
    Kuhn J; Weber M; Hedde JP; Bewermeyer H
    Med Klin (Munich); 2005 Apr; 100(4):209-12. PubMed ID: 15834530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.